Biotech Skyhawk Therapeutics Expands into State-of-the-Art Labs in its Basel, Switzerland Location June 26, 2024
Biotech SKAN, the Wellcome Sanger Institute and University of Newcastle to study early stem cell mutations in rare blood disorder June 25, 2024
Biotech Exsilio Therapeutics Launches with $82 Million Series A Financing to Develop Redosable Genomic Medicines for A Broad Range of Diseases June 25, 2024
Biotech AMSilk to showcase its biofabricated yarns at Europe’s largest trade show, Première Vision Paris June 25, 2024
Biotech Halozyme Announces Roche’s OCREVUS® SC with ENHANZE® Receives European Commission Approval for Relapsing and Primary Progressive Multiple Sclerosis June 25, 2024
Biotech Aetion Launches Barcelona Technology Hub and Appoints Ken Watson as Chief Technology Officer June 25, 2024
Biotech IDEAYA Biosciences Announces Clinical Program Updates for IDE397 a Potential First-in-Class Phase 2 MAT2A Inhibitor Targeting MTAP-Deletion Solid Tumors June 24, 2024
Biotech Juniper Biologics Expands Distribution Rights for Caris Life Sciences’ Molecular Profiling in the Middle East and Africa June 24, 2024
Biotech Ascentage Pharma Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering of American Depositary Shares June 24, 2024